+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Antithrombotic Drugs - Global Strategic Business Report - Product Thumbnail Image

Antithrombotic Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 282 Pages
  • Global
From
Ankylosing Spondylitis - Global Strategic Business Report - Product Thumbnail Image

Ankylosing Spondylitis - Global Strategic Business Report

  • Report
  • July 2025
  • 271 Pages
  • Global
From
From
From
Diverticulitis Disease - Global Strategic Business Report - Product Thumbnail Image

Diverticulitis Disease - Global Strategic Business Report

  • Report
  • July 2025
  • 294 Pages
  • Global
From
From
Rheumatoid Arthritis (RA) Therapy Area Report - Product Thumbnail Image

Rheumatoid Arthritis (RA) Therapy Area Report

  • Report
  • February 2022
  • 65 Pages
  • Global
Non-cancerous Skin Diseases Therapeutics Market 2025-2029 - Product Thumbnail Image

Non-cancerous Skin Diseases Therapeutics Market 2025-2029

  • Report
  • February 2025
  • 222 Pages
  • Global
From
5-Alpha Reductase Deficiency Market Report 2025 - Product Thumbnail Image

5-Alpha Reductase Deficiency Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Interstitial Cystitis - Pipeline Insight, 2025 - Product Thumbnail Image

Interstitial Cystitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dermatological Drugs Market 2024-2028 - Product Thumbnail Image

Dermatological Drugs Market 2024-2028

  • Report
  • July 2024
  • 139 Pages
  • Global
From
Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 183 Pages
  • Global
From
Cystitis- Pipeline Insight, 2025 - Product Thumbnail Image

Cystitis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator